You are here
Advisory Committee on Chemicals Scheduling (ACCS)
Role of the ACCS
The ACCS was established to advise and make recommendations to the Secretary of the Department of Health (or delegate) on the level of access required for chemicals and in some instances medicines
Under revised scheduling arrangements, which took effect on 1 July 2010, the Secretary to the Department of Health (Health) (or the Secretary's delegate) superseded the National Drugs and Poisons Schedule Committee (NDPSC) as the decision maker for the scheduling of medicines and chemicals
Scheduling is a classification system that controls how medicines and chemicals are made accessible to consumers based on the substances contained within them. Substances are grouped into Schedules according to the appropriate level of regulatory control over their availability (e.g. Schedule 4 - medicines available only by prescription; Schedule 2 - medicines available over the counter in pharmacies).
Under the Therapeutic Goods Regulations 1990 (the Regulations), the Committee comprises of nine nominated members and no more than six appointed members.
Under the Therapeutic Goods Act 1989 (the Act), the Commonwealth, each State, the Australian Capital Territory and the Northern Territory are entitled to nominate a member on this Committee. These Committee members are referred to as 'nominated' members.
Under the Regulations, the Minister must appoint no more than six additional members, selected through an open invitation process. These Committee members are referred to as 'appointed' members.
Membership of ACCS comprises professionals with specific scientific, medical or clinical expertise, as well as appropriate consumer health issues relating to chemicals.
Associate Professor John Edwards is a toxicologist and Occupational Hygienist with over 30 years experience in the University sector. His research interests are in the areas of chemical exposure monitoring in workers and the general public. He has been president of the Australian Institute of Occupational Hygiene and is a founding member of the Australasian College of Toxicology and Risk Assessment. He has extensive experience in regulatory toxicology, as he was a member of the Advisory Committee of Chemicals Safety, the Advisory Committee on Complementary Medicines, and has provided expert advice to the Advisory Committee on Safety of Medicines, National Health and Medical Research Council, the Department of Health and the Food Standards Australia New Zealand. He maintains research activities with Adelaide, Flinders and Deakin Universities and operates a toxicology consultancy. Associate Professor Edwards provides expertise in regulatory toxicology.
Adjunct Professor Paul Brent is Adjunct Professor at the Faculty of Agriculture and Food Sciences, University of Laval, Canada where he contributes to the development of coursework for students. He was a medical researcher at the University of Newcastle Medical School, Department of Clinical Pharmacology, then worked at the TGA and Food Standards Australia New Zealand. Professor Brent provides expertise in the field of toxicology or pharmacology.
Mr Jared Brown is the current Head of the New South Wales Poisons Information Centre and is a specialist in poisons and medicines information. He is a registered pharmacist and a Fellow of the Society of Hospital Pharmacists of Australia. Mr Brown is active in clinical toxicology public health research and toxicovigilance at Australasia's largest poisons centre. He previously was the team leader of NPS Medicines Line and Adverse Medicine Events Line. Mr Brown provides expertise in the field of toxicology.
Ms Stephanie Newell is qualified in Occupational Health and Safety and is a past member of the TGA Advisory Committee on the Safety of Vaccines and the Lead Working Committee of the National Health and Medical Research Council of Australia. Ms Newell provides expertise in the field of consumer health issues relating to the regulation of chemicals.
Ms Catherine Oh is a regulatory scientist whose experience includes a regulatory chemist role at Nalco Australia, and her current position as the Regulatory & Technical Manager for Accord Australasia. She has obtained undergraduate qualifications from the University of Sydney and postgraduate qualifications from Griffith University. She is a member of professional bodies Australasian College of Toxicology and Risk Assessment and Royal Australian Chemical lnstitute. Ms Oh provides expertise in the field of the regulation of scheduled chemicals and Australia.
Dr Gladwin Roberts is a toxicologist. He has had extensive experience in the assessment of toxicological data and related information on a variety of chemicals. As a former employee of the Australian Department of Health, he also had responsibility for recommendations on public health standards, including poisons scheduling. He played a major role in the development of hazard criteria for scheduling of chemicals in S5, S6 and S7, as currently used in the Scheduling Policy Framework. Dr Roberts provides expertise in the field of toxicology.
- Dr Kerry Nugent
- Ms Vivien Bevan
Australian Capital Territory
- Mr Peter Gilfedder
New South Wales
- Ms Lisa Hall
- Ms Uma Rajappa
- Dr David Simon
- Mr Sam Halliday
- Mrs Effi Liden
- Ms Jane Carpenter
Meeting dates and decisions timeframes
Stakeholders should note that the timetable outlines the anticipated administrative timeframes associated with matters for the advisory committee. This timetable also reflects public consultation timeframes as required by legislation.
Contact details for the ACCS
|Phone||+61 2 6232 8665|
|Mobile||+61 468 609 842|
|Fax||+61 2 6203 1250|
|Postal Address||Advisory Committee on Chemicals Scheduling
Therapeutic Goods Administration
PO Box 100
WODEN ACT 2606
Attn: Scheduling & Committee Support Section, MDP 122